Free Research Reports on ARR, DRYS, IMUC and SZYM Issued by the Bedford Report
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit
NEW YORK, NY -- (Marketwire) -- 11/16/12 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.
ARMOUR Residential REIT, Inc. (NYSE: ARR) shares rebounded 5.5% Thursday on over 20 million shares traded. The company currently offers investors an annual dividend of $1.08 per share for a yield of approximately 17.7%.
DryShips Inc. (NASDAQ: DRYS) shares fell 17% on nearly 18 million shares traded Thursday. The company's net loss widened to $51.3 million in the third quarter of 2012. Dryships have recently stated that their focus is on reducing and prolonging its capital expenditure program.
ImmunoCellular Therapeutics Ltd. (NYSE: IMUC) is a clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The company's ICT-107 cancer vaccine is anticipated to complete a Phase IIb trial at the end of 2013.
Disclaimer: Equity News Circuit is not a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security. A third party, bedfordreport.com has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release.